Contemporary Strategies and Outcomes of Dedicated Chronic Total Occlusion Percutaneous Coronary Intervention Programs: A Prospective Multicentre Registry.


Journal

Journal of interventional cardiology
ISSN: 1540-8183
Titre abrégé: J Interv Cardiol
Pays: United States
ID NLM: 8907826

Informations de publication

Date de publication:
2021
Historique:
received: 09 09 2021
accepted: 17 11 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 28 12 2021
Statut: epublish

Résumé

The field of CTO PCI is expanding, but successful and safe percutaneous coronary intervention (PCI) of coronary chronic total occlusions (CTO) requires a substantial resource and experience investment. We aimed to assess temporal trends in strategies and outcomes of 2 dedicated programs for CTO PCI. Between 2011 and 2020, 920 CTO PCI procedures were prospectively included at 2 referral centres in Belgium. Temporal trends were assessed, and logistic regression models were built to identify predictors of outcome. Despite an increase in lesion complexity (the J-CTO score increased from 1.3 in year 1 to 1.7-2.0 in years 8-9, Three to four years after initiation of a dedicated CTO PCI program with 50 CTO PCIs per year, consistent high technical success and low complication rates are achieved using contemporary strategies.

Sections du résumé

BACKGROUND BACKGROUND
The field of CTO PCI is expanding, but successful and safe percutaneous coronary intervention (PCI) of coronary chronic total occlusions (CTO) requires a substantial resource and experience investment. We aimed to assess temporal trends in strategies and outcomes of 2 dedicated programs for CTO PCI.
METHODS METHODS
Between 2011 and 2020, 920 CTO PCI procedures were prospectively included at 2 referral centres in Belgium. Temporal trends were assessed, and logistic regression models were built to identify predictors of outcome.
RESULTS RESULTS
Despite an increase in lesion complexity (the J-CTO score increased from 1.3 in year 1 to 1.7-2.0 in years 8-9,
CONCLUSIONS CONCLUSIONS
Three to four years after initiation of a dedicated CTO PCI program with 50 CTO PCIs per year, consistent high technical success and low complication rates are achieved using contemporary strategies.

Identifiants

pubmed: 34949966
doi: 10.1155/2021/8042633
pmc: PMC8670896
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

8042633

Informations de copyright

Copyright © 2021 Maarten Vanhaverbeke et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

JACC Cardiovasc Interv. 2018 Apr 9;11(7):615-625
pubmed: 29550088
Circulation. 2018 Nov 13;138(20):e618-e651
pubmed: 30571511
Eur Heart J. 2018 Jul 7;39(26):2484-2493
pubmed: 29722796
EuroIntervention. 2019 Jun 20;15(2):198-208
pubmed: 30636678
JACC Cardiovasc Interv. 2017 Aug 14;10(15):1523-1534
pubmed: 28797429
JACC Cardiovasc Interv. 2012 Apr;5(4):367-79
pubmed: 22516392
EuroIntervention. 2011 Aug;7(4):472-9
pubmed: 21764666
Circulation. 2019 Apr 2;139(14):1674-1683
pubmed: 30813758
Circ Cardiovasc Interv. 2018 Oct;11(10):e006229
pubmed: 30354635
Acta Cardiol. 2021 Dec;76(10):1043-1051
pubmed: 32755286
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1325-1335
pubmed: 29706508
JACC Cardiovasc Interv. 2020 Jun 8;13(11):1357-1368
pubmed: 32417095
JACC Cardiovasc Interv. 2018 Jul 9;11(13):1309-1311
pubmed: 29976368
Eur Heart J. 2019 Jan 7;40(2):87-165
pubmed: 30165437
JACC Cardiovasc Interv. 2011 Feb;4(2):213-21
pubmed: 21349461
JACC Cardiovasc Interv. 2019 Oct 14;12(19):1915-1923
pubmed: 31601387

Auteurs

Maarten Vanhaverbeke (M)

Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.

Ward Eertmans (W)

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Wouter Holvoet (W)

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Ief Hendrickx (I)

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Keir McCutcheon (K)

Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.
Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

Christophe Dubois (C)

Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.
Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

Joseph Dens (J)

Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.

Johan Bennett (J)

Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.
Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH